From trying to create new cartilage in the laboratory to clinical trials for patients with brain injuries, scientists and physicians at The University of Texas Health Science Center at Houston (UTHealth) are leading the way in stem cell research.
In partnership with Memorial Hermann-Texas Medical Center, UTHealth was the first in the country to intravenously inject a stroke patient’s own stem cells in a trial funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health. Learn how researchers continue to push the boundaries of this promising field.
The use of cell therapy after traumatic brain injury (TBI) in children can reduce the amount of therapeutic interventions needed to treat the patient, as well as the amount of time the child spends in neurointensive care, according to research by The University of Texas Health Science Center at Houston (UTHealth) Medical School.Continue reading »
A first-of-its-kind clinical trial studying two forms of stem cell treatments for children with cerebral palsy (CP) has begun at The University of Texas Health Science Center at Houston (UTHealth) Medical School.Continue reading »